Furthermore, inhibiting caspase-1 has the potential to suppress inflammasome activation, thereby mitigating the severity of experimental autoimmune encephalomyelitis, an animal model frequently utilized to study MS [141]. The gene discussed is CASP1; the disease is myeloid sarcoma.